Pdt Partners, LLC Astria Therapeutics, Inc. Transaction History
Pdt Partners, LLC
- $1 Billion
- Q4 2024
A detailed history of Pdt Partners, LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 10,507 shares of ATXS stock, worth $75,019. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,507
Previous 12,749
17.59%
Holding current value
$75,019
Previous $140,000
34.29%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ATXS
# of Institutions
114Shares Held
50.3MCall Options Held
75KPut Options Held
6.2K-
Perceptive Advisors LLC New York, NY6.49MShares$46.3 Million1.91% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.11MShares$36.5 Million0.73% of portfolio
-
Vestal Point Capital, LP New York, NY4.18MShares$29.8 Million2.22% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$25.4 Million6.29% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$25.1 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $108M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...